American Portfolios Advisors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$11.4K Buy
81
+59
+268% +$10.8K ﹤0.01% 2472
2022
Q2
$4.49K Buy
22
+5
+29% +$1.09K ﹤0.01% 2865
2022
Q1
$4.33K Hold
17
﹤0.01% 2992
2021
Q4
$5.58K Hold
17
﹤0.01% 2855
2021
Q3
$5.14K Hold
17
﹤0.01% 2835
2021
Q2
$4.61K Buy
17
+3
+21% +$761 ﹤0.01% 2852
2021
Q1
$3.41K Buy
+14
New +$3.85K ﹤0.01% 2837
2020
Q4
Sell
-10
Closed -$2.55K 3062
2020
Q3
$2.55K Buy
10
+2
+25% +$475 ﹤0.01% 2514
2020
Q2
$1.73K Buy
+8
New +$1.84K ﹤0.01% 2590

Other funds holding MLAB

American Portfolios Advisors's MLAB Position: Q3 2022 in Review

American Portfolios Advisors increased its Mesa Laboratories (MLAB) stake by 268% in Q3 2022, buying an estimated $10.8K and bringing the position to 81 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

American Portfolios Advisors first reported a position in MLAB in Q2 2020 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • American Portfolios Advisors held 81 shares of Mesa Laboratories worth $11.4K as of Q3 2022.
  • American Portfolios Advisors bought 59 Mesa Laboratories shares in Q3 2022, an estimated $10.8K.
  • Mesa Laboratories made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2472 holding.
  • American Portfolios Advisors first reported a position in Mesa Laboratories in Q2 2020 and has held it in 9 quarters since.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.